胸肌前假体乳房重建的抗生素预防标准
该回顾性队列研究纳入2015至2025年间748例乳房切除后行即刻胸肌前组织扩张器/假体置入的女性,比较24小时与延长至72小时预防性抗生素的效果。倾向评分匹配后每组222例,30天和90天手术部位感染率及感染乳房挽救成功率均无显著差异,提示延长抗生素预防超过24小时不带来额外保护。
要点
- 胸肌前假体乳房重建术后延长抗生素至72小时未降低感染风险。
- 匹配队列30天感染率OR 1.13(95%CI 0.43-2.98,p=0.8),无显著差异。
- 90天感染率及感染乳房挽救成功率两组间亦无显著差异。
核心结论
- 在胸肌前扩张器/假体乳房重建患者中,延长抗生素预防超过24小时不提供抗感染保护优势。
研究设计与样本
- 回顾性队列研究,纳入2015至2025年间在高容量乳房重建中心行乳房切除后即刻胸肌前组织扩张器/假体置入的女性,共748例符合标准。
主要发现
- 344例(46%)接受24小时预防性抗生素,404例(54%)接受延长至72小时的预防性抗生素。
- 倾向评分匹配后每组222例,队列间仅种族和民族存在差异。
- 匹配队列30天手术部位感染率无显著差异(OR 1.13,95%CI 0.43-2.98,p=0.8)。
- 匹配队列90天感染率无显著差异(OR 1.67,95%CI 0.85-3.28,p=0.14)。
- 感染乳房单纯抗生素成功挽救与手术冲洗成功率两组间无显著差异(OR 0.8,95%CI 0.2-3.8,p=1)。
临床怎么用
- 胸肌前假体乳房重建术后可考虑24小时抗生素预防即可,无需常规延长至72小时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative antibiotic prophylaxis after expander/implant-based breast reconstruction is an important consideration, but existing literature is largely focused on subpectoral reconstruction. With the prevailing paradigm shift towards prepectoral reconstruction, there is concern for greater infection risk given less vascularized tissue coverage of the expander/implant when compared to partial or total submuscular approaches, along with adjunct use of acellular dermal matrix. We investigate the optimal duration of postoperative antibiotic prophylaxis specifically for prepectoral expander/implant breast reconstruction with the use of ADM. METHODS: This is a retrospective cohort investigation of women undergoing immediate prepectoral tissue expander/implant placement following mastectomy at a high-volume breast reconstruction center, between 2015 and 2025. RESULTS: In total, 748 women met inclusion criteria. Of these, 344 (46%) received 24 hours of prophylactic antibiotics and 404 (54%) received extended antibiotic prophylaxis up to 72 hours. Following propensity score matching, 222 patients were included in each cohort and study cohorts differed only in terms of race and ethnicity. There were no significant differences in 30-day surgical site infection rates (odds ratio 1.13, 95% confidence interval 0.43 - 2.98, p = 0.8) and 90-day infection rates (odds ratio 1.67, 95% confidence interval 0.85-3.28, p=0.14) between matched cohorts. Similarly, there were no significant differences between cohorts in the rate of successful salvage of infected breasts with antibiotics alone versus surgical washout (odds radio: 0.8, 95% confidence interval 0.2-3.8, p=1). CONCLUSIONS: Extending antibiotic prophylaxis beyond 24 hours does not confer protective advantage against infection amongst patients undergoing prepectoral expander/implant-based breast reconstruction.
引用
- Yesantharao PS, Jing SL, Magon H, et al. Antibiotic Prophylaxis in Prepectoral Alloplastic Breast Reconstruction: Establishing Standards. Plast Reconstr Surg. 2026. PMID: 42447365. doi:10.1097/PRS.0000000000013330
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。